CategoryBiometric wearables
Overview
Synchron is a brain-computer interface (BCI) company developing the Stentrode, a stentrode-based BCI implant that does not require open-brain surgery. Founded by neurologist Tom Oxley, the company has raised over $345M in total funding including a $200M Series D in 2024. Synchron's COMMAND and Switch clinical trials demonstrated no serious device-related adverse events across 6 patients, and the FDA has approved the Stentrode for early feasibility studies. The company is based in New York with origins in Melbourne, Australia.
Verified record
- Verified deployments
- 5 deployments on file
- Active incidents
- None on file
Key facts
CEO
Product
Safety
Target
Data & sources
Web sources
1
1 source backing this record.View all →
Models (1)
View all models →Synchron on the deployment map
View the global map5 verified deployments across 3 regions, newest verified Jan 2023. Explore where Synchron's robots are operating, by place and type.
- operationalSynchron Stentrode at Buffalo, New York, USA →Northeast · verified Jan 2023
- operationalSynchron Stentrode at Pittsburgh, Pennsylvania, USA →Northeast · verified Oct 2022
- operationalSynchron Stentrode at New York, New York, USA →Northeast · verified Jan 2021
- operationalSynchron Stentrode at Jacksonville →Florida · verified Jan 2021
- operationalSynchron Stentrode at Melbourne, Victoria, Australia →Oceania · verified Jan 2019
View the full Synchron deployment record →
Relationships
Current leadership (1)
- Tom Oxley Founder & CEOreported, not verified
Founders (1)
- Tom Oxleycofounder
Safety record
No incidents on record for Synchron.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Operator customers (1)
- Synchron5 deployments
Recent coverage
Synchron in third-party press
Peers
3 peers across 1 segment. Every Synchron competitor derived from shared form-factor and application-domain edges.
bci(3)
3 companies in this segment · highly_concentrated (HHI 3365.5523463639224) · leader Blackrock Neurotech at 3565%
- Blackrock Neurotechdirect competitor(inferred)strong
- Paradromicsdirect competitor(inferred)strong
- Precision Neurosciencedirect competitor(inferred)strong
Mentioned on (1)
Registry pages whose text names Synchron.
People (1)
Financial state
- Total funding
- $200.0M
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Funding rounds (1)
- Series D2024-12-01
$200M(reported)
Investors: Khosla Ventures, Temasek, Jeff Bezos / Bezos Expeditions, Qatar Investment Authority (QIA), In-Q-Tel
Timeline
Every recorded move in Synchron’s history, most recent first: funding rounds, partnerships, acquisitions, supply-chain starts, key hires, and press.
Funding roundSeries D funding round
2024-12-01Series D raising $200000000
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJul 6, 2026
Added to the verified registry
- Deployment verifiedVerifiedJan 1, 2023
Synchron Stentrode at Buffalo, New York, USA
- Deployment verifiedVerifiedOct 27, 2022
Synchron Stentrode at Pittsburgh, Pennsylvania, USA
- Deployment verifiedVerifiedJan 1, 2021
Synchron Stentrode at Jacksonville
- Deployment verifiedVerifiedJan 1, 2021
Synchron Stentrode at New York, New York, USA
Sources (1)
Common questions
What is Synchron?
What does Synchron make?
Is Synchron publicly traded?
Who competes with Synchron?
Who is the CEO of Synchron?
How can I invest in Synchron?
How much funding has Synchron raised?
Who owns Synchron?
Where does Synchron operate robots?
How many robots has Synchron deployed?
Is Synchron a top robotics company?
When was Synchron founded?
Is Synchron safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-21
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-21
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Synchron.Peer companies
- Google12 models
- Samsung Electronics6 models
- Abbott2 models
- Butterfly Network2 models
- Apple1 model
- Blackrock Neurotech1 model
In the press
Recent coverage mentioning Synchron from third-party publications. Automatically surfaced; not part of the verified registry record.
Brain-computer interface based on Rice research wins FDA approval for first clinical trial
A brain-computer interface based on Rice University research won FDA approval for its first clinical trial, advancing BCI technology for patients with paralysis or amputation.
Synchron raises $200M Series D to support BCI commercialization
Synchron raised $200M in Series D financing to support commercialization of its Stentrode brain-computer interface, bringing total funding to over $345M and pushing BCI investment…
Synchron's Brain-Computer Interface Evaluated in COMMAND Early Feasibility Study
Synchron's COMMAND study showed reliable performance of the Stentrode BCI implant with no serious adverse events related to the brain or vasculature during the 12-month period…
Machine-readable surfaces
- Markdown mirror: /companies/synchron.md
- RSS feed: /companies/synchron/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/ac5afad9-cfd5-4b66-aa18-4d3aacf16560
- Revision history: /companies/synchron/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Google12 models
- Samsung Electronics6 models
- Abbott2 models
- Butterfly Network2 models
- Apple1 model
- Blackrock Neurotech1 model
Video
Hello, world! Meet Rodney - one of our heroes. Living with ALS, he's redefining independence using the Synchron brain-computer interface (BCI) + NVIDIA Holoscan + Apple Vision Pro to control his digital devices. In thi
A group of humanoid robots showed off their synchronized Kung Fu moves at China’s Spring Festival Gala. See the stunning tech performance.
Cobot, track and manipulator move in perfect sync. Delivering smooth, precise welds even on complex workpieces with the WeCobot ONE welding software. ⚙️ Practi
What other uses for BCI would you like to see? Share them in the comments. Elon Musk should start working on improving Neuralink to keep up with Synchron. Syn
Hello everyone, today we look at a company called Synchron. They are the first ones ever to connect a Brain Computer Interface (BCI) to an Apple Vision Pro. Nex
Synchron's lab automation intelligence makes it possible to create automation processes for every type of laboratory. By integrating smart robot solutions we ma
Synchron's lab automation intelligence makes it possible to create automation processes for every type of laboratory. By integrating smart robot solutions we ma
Synchron's lab automation intelligence makes it possible to create automation processes for every type of laboratory. By integrating smart robot solutions we ma
Synchron's lab automation intelligence makes it possible to create automation processes for every type of laboratory. By integrating smart robot solutions we ma
Thank you for visiting us at our booth during Lab Automation 2022. Hope you have enjoyed the experience! We sure did! Synchron's lab automation intelligence m
Synchron's lab automation intelligence makes it possible to create automation processes for every type of laboratory. By integrating smart robot solutions we ma
Synchron's lab automation intelligence makes it possible to create automation processes for every type of laboratory. By integrating smart robot solutions we ma
Dive into the defining debate shaping the future of medical neurotechnology by comparing the two leading brain-computer interface (BCI) platforms: Neuralink and
Synchron's lab automation intelligence makes it possible to create automation processes for every type of laboratory. By integrating smart robot solutions we ma
Heat Index
Serious53/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
Synchron draws attention at the 48th percentile but verifies reality at the 90th percentile among biometric robots. Hype Gap -41.9, 27th widest among biometric robots.
6-month trend
Analysis
Clean safety record across 5 verified deployments. Limited public visibility and press coverage relative to peers.
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Nov 20, 2026